Efficacy of Ashwagandha (withania somnifera [l.] Dunal) in improving cardiorespiratory endurance (VO2 max test) in healthy subjects
In Ayurveda, certain herbal formulas are considered to be Rasayana and they are typically taken over periods of time to regenerate both brain and body tissue. Ashwagandha (Withania Somnifera) is used as an adaptogen, antioxidant, immune modulator, free radical scavenger, anti stress, anti arthritic, antispasmodic, anti inflammatory, nervous tonic, nerve soothing and anticancer agent. Ashwagandha (WS) as a nutritional supplement is yet too established. Maximum oxygen uptake (VO2 max) is a gold standard of cardiopulmonary and muscle cell fitness is considered. The study evaluated the efficacy of Ashwagandha to improve cardiorespiratory endurance (VO2 max) in healthy subjects. They randomized single blind controlled comparative clinical study. 54 health volunteers in each group, study group received Ashwagandha Choorna 12gm with milk (200ml) empty stomach in the morning and the control group only milk (200ml). Maximal capacity of oxygen intake in ml/kg/min (VO2 max) with Rockport fitness walking test of both study and control group were measured before intervention (0th day), after the intervention (60th day) and follow up (90th day). A significant improvement in the VO2 max (F=20.675, P <0.0001) and Hemoglobin (X2=74.150 P <0.0001) in the study group was found. Supplementation of Ashwagandha (Withania Somnifera) with milk improve hemoglobin and VO2 max (maximum aerobic capacity).
Keywords:Ashwagandha, Cardiorespiratory Endurance, Haemoglobin, Physical Fitness, VO2 Max (Maximal Aerobic Capacity), Withania Somnifera
Bhandari, C. 1970. Ashwagandha (Withania somnifera). ’Vananushadhi Chandroday’ (An encyclopaedia of India herbs) publisher C S series of Varanasi Vidyavilas press, Varanasi India 1:96-97.
Bhattacharya, S. K., Muruganandam, A. V. 2003. Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacology Biochemistry and Behavior, 75(3):547–555.
Choudhary, B., et al. 2015. Efficacy of Ashwagandha (Withania somnifera [L.] Dunal) in improving cardiorespiratory endurance in healthy athletic adults. International Quarterly Journal of Research in Ayurveda, 36(1):63–68.
Chunekar, K. C., Pandey, G. S. 2010. Bhavaprakasha Nighantu of Bhavamishra. Varanasi: Chaukhambha Bharati Academy, pp. 393.
Dhuley, J. N. 1998a. Effect of ashwagandha on lipid peroxidation in stress-induced animals. Journal of Ethnopharmacology, 60(2):173–178.
Dhuley, J. N. 1998b. Therapeutic efficacy of ashwagandha against experimental aspergillosis in mice. Immunopharmacology and Immunotoxicology, 20(1):191–198.
Kline, G. M., et al. 1987. Estimation of VO2 max from a one-mile track walk, gender, age and body weight. Medicine & Science in Sports & Exercise, 19(3):253–259.
Končić, M. Z. 2018. Getting more than you paid for unauthorized ”natural” substances in herbal food supplements on EU market. Planta Medica, 84(06/07):394–406.
McSwegin, P. J., et al. 1998. The validity of a one-mile walk test for high school age individuals. Measurement in Physical Education and Exercise Science, 2(1):47–63.
Mishra, L. C., et al. 2000. The scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Journal of Clinical Therapeutic, 5(4):334–346.
Sangwan, R. S., et al. 2004. Phytochemical variability in commercial herbal products and preparations of Withania somnifera (Ashwagandha). Current Science, 86(3):461–465.
Setty, P., et al. 2013. Correlation between obesity and cardio respiratory fitness. International Journal of Medical Science and Public Health, 2(2):300–304.
Sharma, P. C., et al. 2001. Database on medicinal plants used in Ayurveda. Agris, 3:1–4.
Sharma, P. V. 1999. Dravyaguna Vijnana. Varanasi: Chaukhambha Bharti Academy. Pages: 168-177.
Ziauddin, M., et al. 1996. Studies on the immunomodulatory effects of Ashwagandha. Journal of Ethnopharmacology, 50(2):69–76.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.